Search results
Author(s):
Thomas J Povsic
Added:
3 years ago
The potential of physiological regeneration offered by stem-cell-mediated therapy has captured the imagination of both the public and the scientific community. This is especially true for the cardiovascular and nervous systems, which have long been considered terminally differentiated and post-mitotic with minimal capacity for regeneration and repair.
While the ability of embryonically derived…
View more
Author(s):
Michael R Rosen
Added:
3 years ago
Cardiac arrhythmia diagnosis is as old as the Bible and ancient Chinese literature.1 Treatment has progressed from the natural products used by the ancients, to formalized attempts at pharmacological therapy over the last 300 years (with digitalis and cinchona bark being the lead compounds), to the modern use of devices and ablation. However, with the exception of electronic pacing for…
View more
Author(s):
David S Rosenbaum
Added:
3 years ago
Heart disease is the leading cause of death in the US with 700,000 deaths annually, of which 460,000 are attributable to sudden cardiac death (SCD).1,2 SCD is usually attributed to ventricular fibrillation (VF). Despite recent reductions in cardiac mortality from other causes, the incidence of SCD remains high with minimal decline in the last decade. The large majority of patients who suffer life…
View more
Author(s):
Shaun R Opie
,
Nabil Dib
Added:
3 years ago
Cardiovascular disease is the leading cause of death in Western countries. The damage that occurs during a heart attack results from the death and loss of the cells called cardiomyocytes that make up the majority of the myocardium. Medical therapy, balloon angioplasty, stent deployment, coronary artery bypass surgery, and heart transplantation are the current options available to the patient…
View more
Author(s):
Denton A Cooley
Added:
3 years ago
Innovative technologies and refinements of existing therapies are shaping 21st century cardiovascular diagnosis and treatment. Researchers are gaining new perspectives on diseases and their treatment at the cellular and subcellular levels. Cardiologists are evaluating and treating coronary arteries by means of intravascular intervention. Surgeons are shortening recovery times and increasing cost…
View more
Joseph C. Wu
Research Area(s) / Expertise:
Job title: Director
Author
Kristine Jang
Job title: Cardiologist
Author
Marco Valgimigli
Job title: Deputy Chief of Cardiology
Author
Author(s):
Brian Pearlman
,
Taffere Mihretu
Added:
3 years ago
Congestive heart failure (CHF) is a rapidly growing public health problem, affecting nearly five million people in the US alone, with nearly half a million new cases annually.The prevalence of CHF is highest in the elderly; ten out of every 1,000 persons over age 65 are affected. Anemia has been considered a modifiable comorbidity in heart failure. Utilizing the World Health Organization (WHO)…
View more
Author(s):
David N Kenigsberg
,
Ken Ellenbogen
Added:
3 years ago
Atrial fibrillation (AF) is a common and recurrent arrhythmia resulting in significant morbidity and mortality. Our approach to the patient with AF has changed dramatically over the past decade. We have gone from palliating patients with rate controlling medications or administering antiarrhythmic medications with potential systemic side effects and proarrhythmia, to now curing many of them with…
View more